Navigation Links
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
Date:6/25/2009

ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting

RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc. (NYSE: KG) today announced that the Company is presenting safety and efficacy data for ACUROX(R) and EMBEDA(TM) (ALO-01), two novel opioid analgesic formulations that are in development, at the 71st Annual Meeting of the College on Problems of Drug Dependence. King is also developing other pain medicines employing unique technology platforms designed to address risks associated with currently marketed opioids.

"We anticipate that ACUROX(R) and EMBEDA(TM), upon approval, will offer new therapeutic tools for physicians treating people living with pain," said Eric Carter, Chief Science Officer of King Pharmaceuticals. "Our expectation is that these novel technologies could become instrumental in a physician's arsenal of safe and effective pain medicines that can help with an overall risk management plan."

Highlights of King's presentations and King supported presentations are as follows:

ACUROX(R) (oxycodone HCl/niacin) Tablets for the Treatment of Acute, Moderate to Severe Pain Following Bunionectomy Surgery in Adult Patients

ACUROX(R) Tablets are a unique composition of short-acting oxycodone HCl, niacin and functional inactive ingredients intended to relieve moderate to severe pain. A Phase III study evaluated the analgesic efficacy and safety of ACUROX(R) in adults with moderate to severe pain following bunionectomy surgery. The 405 participants received either two ACUROX(R) Tablets 7.5/30 mg, two ACUROX(R) Tablets 5/30 mg or two placebo tablets every six hours for 48 hours after surgery. Both doses of ACUROX(R) Tablets demonstrated significant reduction in pain compared to placebo. The adv
'/>"/>

SOURCE King Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... -- Today the US Surgeon General issued the most stern warning ... burns stating they can lead directly to deadly melanoma skin ... says that "skin cancer is a major public health problem ... indoor and outdoor ultraviolet light is a major cause." At ... Boca Raton, Florida , Marta I. Rendon ...
(Date:7/30/2014)... , July 30, 2014 Research ... "Global and Chinese Aseptic Packaging Industry Report 2014" ... http://photos.prnewswire.com/prnh/20130307/600769 The Global and Chinese ... study on the current state of the global Aseptic ... The report provides a basic overview of the ...
(Date:7/30/2014)... 30, 2014  InnoPharma, Inc. today announced the first ... equivalent of Zyprexa® injection), in Canada.  Olanzapine is indicated ... in patients with schizophrenia or bipolar I mania. ... InnoPharma has entered into an agreement with Sandoz Canada ... make, use, sell, market and distribute Olanzapine Injection in ...
Breaking Medicine Technology:Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer 2Global and Chinese Aseptic Packaging Industry Report 2014 2InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2
... Life Technologies Corporation (NASDAQ: ... an agreement with GlaxoSmithKline Biologicals S.A. (GSK) to develop ... with a GSK candidate cancer immunotherapy. Specifically, Life will ... cancer immunotherapy candidate designed to identify patients likely to ...
... Desert Radiologists has earned Breast MRI accreditation from ... first facility in Las Vegas to receive this prestigious ... that the breast MRI at Desert Radiologists meets ACR,s ... quality control procedures and quality assurance programs. ...
Cached Medicine Technology:Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics 2Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics 3Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics 4Desert Radiologists Earns ACR Breast MRI Accreditation 2
(Date:7/30/2014)... Serial entrepreneur, Paul Mata, spent the early ... like most people, in 2008 he suffered extreme financial hardship ... way, Paul carefully studied the difference between people who have ... Based on the knowledge he acquired, he was able to ... and health, but also grow his clients' personal and financial ...
(Date:7/30/2014)... , Resistance to artemisinin, the main drug to ... among the Plasmodium falciparum ( P. ... is likely caused by a genetic mutation in ... combination therapyas opposed to a standard three-day coursehas ... according to findings published today in the ...
(Date:7/30/2014)... Volunteers from the Church of Scientology ... this summer with massive distribution of Truth About ... these volunteers on Strøget, the famous Copenhagen walking street. ... shopping and its ambiance, some quarter of a million ... day. , These activities are part of a ...
(Date:7/30/2014)... July 30, 2014 Visitors to our ... over $8,500 to ensure its protection. Bob Kiesendahl, one ... check to the Delaware Highlands Conservancy for donations collected ... small $2-per-stay donations add up fast, as visitors welcome ... Upper Delaware River Region. , The Kiesendahl family has ...
(Date:7/30/2014)... A new network of 25 regional stroke centers and ... StrokeNet) is working to change the way stroke ... of the last two decades, stroke remains a major ... disability for 795,000 Americans. The numbers are expected to ... , To accelerate the pace of progress, NIH StrokeNet ...
Breaking Medicine News(10 mins):Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 3Health News:Resistance to key malaria drug spreading at alarming rate in Southeast Asia 2Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2Health News:Kessler funded as satellite site for NIH Stroke Trials Network 2
... www.deo.ucsf.edu , has been launched by the University of California, ... successful American Diabetes Association (ADA) accredited teaching program curriculum created by ... the past 30 years. , ... SAN FRANCISCO ...
... Successful And Effective Campaign Could Help Prevent,Another Blood Crisis, ... Just Six Coaches, Orlando Has 35!!!, NEW YORK, ... a dangerous blood emergency, New York City Councilman Eric ... and,Investigation, and representatives of New York Blood Center called ...
... Findley Davies announced today,the hiring of Tod ... Charlotte,Office effective August 1, 2008. He will be ... Benefits Practice in North Carolina and,surrounding areas. Tod ... as a Health and Welfare consultant for a ...
... new report on severe sporting injuries among high school ... a larger proportion of all such injuries than previously ... of North Carolina at Chapel Hill-based National Center for ... for 65.1 percent of all catastrophic sports injuries among ...
... Aug. 11 STAAR Surgical,Company (Nasdaq: STAA ... invasive ophthalmic products, announced today that it will,present ... Financial Equity,Conference which will be held Monday, August ... Lake Las Vegas Resort, Nevada. Barry G. Caldwell,President ...
... Consumables Revenue Up 15% Year over Year ... Gross Profit Margin of 77%, HAYWARD, ... non-invasive tissue tightening in the aesthetic,industry, today reported its financial results for ... of 2008 totaled $17.9 million, an,increase of 2% from $17.5 million for ...
Cached Medicine News:Health News: 80 Million Americans Can Benefit from New Diabetes Resource : Free Educational Website Created by UCSF Diabetes Teaching Center Goes Live 2Health News:Gioia & New York Blood Center Call for City Aid in Expansion of Mobile Blood Donor Coach Program 2Health News:Gioia & New York Blood Center Call for City Aid in Expansion of Mobile Blood Donor Coach Program 3Health News:UNC study: Two-thirds of severe sports injuries to female students due to cheerleading 2Health News:STAAR Surgical to Present at the Noble Financial Equity Conference 2Health News:Thermage Announces Second Quarter 2008 Financial Results 2Health News:Thermage Announces Second Quarter 2008 Financial Results 3Health News:Thermage Announces Second Quarter 2008 Financial Results 4Health News:Thermage Announces Second Quarter 2008 Financial Results 5Health News:Thermage Announces Second Quarter 2008 Financial Results 6Health News:Thermage Announces Second Quarter 2008 Financial Results 7Health News:Thermage Announces Second Quarter 2008 Financial Results 8Health News:Thermage Announces Second Quarter 2008 Financial Results 9
... providers can code the charge while completing a ... while away from office, both directly feeding the ... an Encounter Form/Superbill, data entry can be done ... patient payments are posted by reflecting open item ...
The CH 2000 Cardiac Diagnostic system is a fully featured stress testing system that can include Microvolt T-Wave Alternans (MTWA) testing capability as an add-on feature. , ,Interfaces with Tra...
The HearTwave system is the original stand-alone Microvolt T-Wave Alternans (MTWA) testing platform....
... features 4 precisely angled 64° mirrors to ... anterior chamber angle with slight rotation. ... element) provides a stable platform during laser ... mirror lens provides a complete view of ...
Medicine Products: